The team

Computational neuroscience, animal behavior, digital health.

NeuroNose sits at an unusual intersection of disciplines — and the founding team was assembled to match. Each founder leads a domain the company genuinely depends on.

Dra. Rosalba Aguilar Velázquez

Dra. Rosalba Aguilar Velázquez

Co-Founder · CEO · Digital Health

Rosalba is a researcher at Universidad Veracruzana and a member of Mexico's National System of Researchers. Her work centers on digital health platforms, clinical decision-support systems, and software for neurological disorders — the discipline that turns a biological signal into a usable screening product.

She has peer-reviewed publications across MDPI Healthcare, Sustainability, and AppliedMath, and brings the product, data, and digital-health perspective that shapes how NeuroNose's screening service reaches and serves patients. As CEO she leads NeuroNose's overall strategy, operations, and fundraising, and continues to direct the digital-health side of the business.

Digital health platforms Clinical decision support National System of Researchers
Dr. Pedro Paredes Ramos

Dr. Pedro Paredes Ramos

Co-Founder · Animal Behavior & Detection

Pedro holds a PhD in Neuroethology from Universidad Veracruzana and is faculty in Veterinary Medicine, as well as a member of Mexico's National System of Researchers (Level I). His research spans animal cognition, olfactory training, and behavioral protocols — precisely the expertise that NeuroNose's Phase 1 service is built on.

He leads NeuroNose's Mexico operations, where the trained-animal detection protocols are designed, validated, and run. The rigor of the published canine-detection literature depends on careful, double-blind behavioral methodology; Pedro is the founder who ensures NeuroNose's protocols meet that standard.

Neuroethology (PhD) Olfactory training protocols Veterinary Medicine faculty
Jovan David Rebolledo Mendez

Jovan David Rebolledo Mendez

Co-Founder

Jovan is a Staff Scientist at the Okinawa Institute of Science and Technology (OIST), in the Neural Computation Unit led by Prof. Kenji Doya, where his research focuses on computational neuroscience and AI for neurodegenerative disease modeling.

He is Director of Exponential Japan KK and has spent 15+ years building Japan's innovation ecosystem, including work as an AI XPRIZE Ambassador for Japan. As a co-founder he shapes NeuroNose's scientific direction and its path into the Japanese market. He holds no executive officer role in the company — a deliberate separation from his OIST research appointment.

Computational neuroscience OIST · Neural Computation Unit AI XPRIZE Ambassador
Scientific advisor

The hardware perspective for Phase 2.

Kevin Max
Scientific Advisor · Olfaction & Neuromorphic Hardware

Kevin Max is a computational neuroscientist working on learning, olfaction, and neuromorphic hardware (arXiv:2504.10053). His group studies how the fruit fly's olfactory system discriminates millions of odors with high precision, and he is prototyping a bio-inspired sensing device for odor identification. He advises NeuroNose on the Phase 2 sensor concept. He is an advisor, not a co-founder.

Building something that matters, with people who can.